HEMACAPE ApS: Financial statements 2022
CVR: 35817115
HEMACAPE ApS (CVR 35817115) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -3,688 and a net result of DKK -3,688 compared with DKK -3,555 the year before. Equity amounted to DKK 82,474. The solvency ratio was 31.4%.
- Gross Profit
- -3,688 kr.
- Profit/Loss
- -3,688 kr.
- Equity
- 82,474 kr.
- Total Assets
- 262,917 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -4 t. | -4 t. | 82 t. | 0 |
| 2021 | - | -3 t. | -4 t. | 86 t. | 0 |
| 2020 | - | -3 t. | -3 t. | 90 t. | 0 |
| 2019 | - | -3 t. | -3 t. | 93 t. | - |
| 2018 | - | -3 t. | -3 t. | 96 t. | - |
Keep an eye on HEMACAPE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
HEMACAPE ApS has published its annual report for 2021. Gross profit came to DKK -3,494, and the net result was DKK -3,555.
About HEMACAPE ApS
HEMACAPE ApS is a Danish company of the type Anpartsselskab based in Randers NØ, founded in 2014. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of John Holflod Jeppesen. The company is owned by John Holflod Jeppesen. In 2025, the company reported a gross profit of DKK -5,843 and a net result of DKK 537,377 compared with DKK -3,750 the year before. Equity amounted to DKK 612,350.
